Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 6, 2014, Pages

  Bergmann, Karl Christian ^a   Demoly, Pascal ^b   Worm, Margitta ^a   Fokkens, Wytske J ^c   Carrillo, Teresa ^d   Tabar, Ana I ^e   Nguyen, Hélène ^f   Montagut, Armelle ^f   Zeldin, Robert K ^f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e Instituto de Investigación Sanitaria de Navarra   (Spain)

^f Stallergenes SA   (France)

Author keywords

Allergic rhinitis; double blind; house dust mite; placebo controlled; sublingual immunotherapy tablets

Indexed keywords

HOUSE DUST ALLERGEN; PLACEBO; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ADULT; ALLERGIC RHINITIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; APPLICATION SITE REACTION; ARTICLE; ASTHMA; AVERAGE ADJUSTED SYMPTOM SCORE; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSPNEA; ECZEMA; EDEMA; FEMALE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; METRORRHAGIA; MOUTH EDEMA; MULTICENTER STUDY; NAUSEA; ORAL PRURITUS; OVARY ABSCESS; PHARYNX EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SCORING SYSTEM; SUBLINGUAL EDEMA; SYMPTOMATOLOGY; TABLET; THROAT IRRITATION; TREATMENT OUTCOME; URTICARIA; VAGINAL INJURY; VAGINAL LACERATION; WHEEZING; ALLERGY RAPID TEST; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DRUG WITHDRAWAL; DYSPEPSIA; EAR PRURITUS; FEVER; HEADACHE; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA; INNER EAR DISEASE; INTOXICATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHARYNGEAL EDEMA; PHARYNGITIS; PHASE 1 CLINICAL TRIAL (TOPIC); RHINITIS TOTAL SYMPTOM SCORE; RHINOPHARYNGITIS; SENSITIZATION; SKIN DISEASE; SORE THROAT; TONGUE EDEMA; UPPER RESPIRATORY TRACT INFECTION;

ALLERGIC RHINITIS; DOUBLE-BLIND; HOUSE DUST MITE; PLACEBO-CONTROLLED; SUBLINGUAL IMMUNOTHERAPY TABLETS;

ADMINISTRATION, SUBLINGUAL; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; SKIN TESTS; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901807832     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.11.012     Document Type: Article

References (32)

1. J. Bousquet, N. Khaltaev, A.A. Cruz, J. Denburg, W.J. Fokkens, and A. Togias et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 Suppl 86 2008 8 160 (Pubitemid 351357811)
2. R.A. Nathan The burden of allergic rhinitis Allergy Asthma Proc 28 2007 3 9
3. R. Pawankar, G. Canonica, S. Holgate, and R. Lockey WAO white book on allergy 2011 World Allergy Organization Milwaukee (WI)
4. J.M. Rowe-Jones The link between the nose and lung, perennial rhinitis and asthma - is it the same disease? Allergy 52 1997 20 28 (Pubitemid 27288310)
5. G.S. Rachelefsky National guidelines needed to manage rhinitis and prevent complications Ann Allergy Asthma Immunol 82 1999 296 305 (Pubitemid 29141092)
6. A. Linneberg, N. Henrik Nielsen, L. Frolund, F. Madsen, A. Dirksen, and T. Jorgensen The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study Allergy 57 2002 1048 1052 (Pubitemid 35238642)
7. L. Cox, H. Nelson, R. Lockey, C. Calabria, T. Chacko, and I. Finegold et al. Allergen immunotherapy: A practice parameter third update J Allergy Clin Immunol 127 Suppl 2011 S1 S55
8. E. Fernandez-Caldas, V. Iraola, M. Boquete, A. Nieto, and M. Casanovas Mite immunotherapy Curr Allergy Asthma Rep 6 2006 413 419 (Pubitemid 44340174)
9. S. Radulovic, M.A. Calderon, D. Wilson, and S. Durham Sublingual immunotherapy for allergic rhinitis Cochrane Database Syst Rev 12 2010 CD002893
10. G.W. Canonica, and G. Passalacqua Disease-modifying effect and economic implications of sublingual immunotherapy J Allergy Clin Immunol 127 2011 44 45
11. G.W. Canonica, J. Bousquet, T. Casale, R.F. Lockey, C.E. Baena-Cagnani, and R. Pawankar et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009 Allergy 64 Suppl 91 2009 1 59
12. A.O. Eifan, M.H. Shamji, and S.R. Durham Long-term clinical and immunological effects of allergen immunotherapy Curr Opin Allergy Clin Immunol 11 2011 586 593
13. H. Mosbech House dust mite allergy Allergy 40 1985 81 91 (Pubitemid 15126766)
14. T.B. Casale, G.W. Canonica, J. Bousquet, L. Cox, R. Lockey, and H.S. Nelson et al. Recommendations for appropriate sublingual immunotherapy clinical trials J Allergy Clin Immunol 124 2009 665 670
15. P.J. Bousquet, M.A. Calderón, P. Demoly, D. Larenas, G. Passalacqua, and C. Bachert et al. The Consolidated Standards of Reporting Trials (CONSORT) statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article J Allergy Clin Immunol 127 2011 49 56.e11
16. P. Demoly, L. Meziane, M. Le Gall, C. André, and M. Melac Safety and tolerability of house dust mite tablets in sublingual immunotherapy J Allergy Clin Immunol 121 Suppl 2008 S128
17. G.W. Canonica, C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, and H.J. Malling et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324
18. J.M. Grouin, E. Vicaut, S. Jean-Alphonse, P. Demoly, U. Wahn, and A. Didier et al. The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials Clin Exp Allergy 41 2011 1282 1288
19. S. Guez, C. Vatrinet, R. Fadel, and C. André House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: A double-blind, placebo-controlled study Allergy 55 2000 369 375 (Pubitemid 30183056)
20. J.E. Solari, J. Loo, A. Felices, and J. Casas Immunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy Allergol Immunopathol 34 2006 102 106 (Pubitemid 43967258)
21. R. Tahamiler, G. Saritzali, S. Canakcioglu, E. Ozcora, and A. Dirican Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis ORL J Otorhinolaryngol Relat Spec 70 2008 144 150 (Pubitemid 351595108)
22. A. Yukselen, S.G. Kendirli, M. Yilmaz, D.U. Altintas, and G.B. Karakoc Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: A randomized, placebo-controlled, double-blind, double-dummy study Int Arch Allergy Immunol 157 2012 288 298
23. A.I. Tabar, S. Echechipia, B.E. Garcia, J.M. Olaguibel, M.T. Lizaso, and B. Gomez et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus J Allergy Clin Immunol 116 2005 109 118 (Pubitemid 40909756)
24. A.O. Eifan, T. Akkoc, A. Yildiz, S. Keles, C. Ozdemir, and N.N. Bahceciler et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: An open randomized controlled trial Clin Exp Allergy 40 2010 922 932
25. V. Bauchau, and S.R. Durham Prevalence and rate of diagnosis of allergic rhinitis in Europe Eur Respir J 24 2004 758 764 (Pubitemid 39504428)
26. A. del Cuvillo, J. Sastre, J. Bartra, J. Mullol, I. DaVila, and J. Montoro et al. Placebo effect in clinical trials involving patients with allergic rhinitis J Investig Allergol Clin Immunol 21 Suppl 3 2011 40 45
27. A.S. Nayak, G. Philip, S. Lu, M.P. Malice, and T.F. Reiss Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial performed in the fall Ann Allergy Asthma Immunol 88 2002 592 600 (Pubitemid 36183813)
28. E. Meltzer, K. Malmstrom, S. Lu, B. Prenner, L. Wei, and S. Weinstein et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial J Allergy Clin Immunol 105 2000 917 922 (Pubitemid 30324400)
29. A.I. Tabar, E. Arroabarren, S. Echechipia, B.E. Garcia, S. Martin, and M.J. Alvarez-Puebla Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy J Allergy Clin Immunol 127 2011 57 63 e1-3
30. G. Passalacqua, and G.W. Canonica Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety Immunol Allergy Clin North Am 31 2011 265 277
31. A. Didier, H.J. Malling, M. Worm, F. Horak, S. Jäger, and A. Montagut et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis J Allergy Clin Immunol 120 2007 1338 1345 (Pubitemid 350225683)
32. U. Wahn, A. Tabar, P. Kuna, S. Halken, A. Montagut, and O. de Beaumont et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis J Allergy Clin Immunol 123 2009 160 166.e3